In this issue:
- A primary care guide for managing ADHD medication side effects
- The immediate management of patients with acute coronary syndrome
- Glucagon-like peptide-1 receptor agonists: stay hydrated
- Less frequent GLP-1 receptor agonist dosing for weight maintenance
- An update on long- and short-acting contraceptive methods
- Weight loss in a culturally diverse, low-income population
- AI-assisted insulin titration for type 2 diabetes
- GPs and nurse practitioners able to start ADHD treatment in 2026
- Pharmac proposes changes to support 12-month prescriptions
- MARC’s remarks: March 2025 meeting
- The reality of the funding and workforce crisis in primary care
- Real-world initiation of empagliflozin and dulaglutide for type 2 diabetes in NZ
- Cardiovascular disease assessment and management gaps for Māori and Pacific
- Psychiatrist granted approval to prescribe psilocybin
Please login below to download this issue (PDF)